StockDrifts LogoStockDrifts

CTC Bio 060590

Company
씨티씨바이오CTC Bio
Insiders
0
Buys
0
Total Value
—
Avg Return
—
Last Filing
2025-10-27

CTC Bio (060590) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for CTC Bio is dated 2025-01-23; the most recent is 2025-10-27.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2025-10-27BUY장외매수
바이오노트
bionote
-2.6M₩5,340-18.9%₩13.7B ($9.5M)
2025-10-27SELL장외매도
파마리서치
Pharma Research
--2.6M₩5,340+18.9%₩13.7B ($9.5M)
2025-04-15BUY장외매수
파마리서치
Pharma Research
-700.0K₩7,100-39.0%₩5.0B ($3.5M)
2025-04-15BUY시간외매매
파마리서치
Pharma Research
-252.7K₩7,100-39.0%₩1.8B ($1.2M)
2025-04-10BUY장외매수
바이오노트
bionote
-763.7K₩6,630-34.7%₩5.1B ($3.5M)
2025-04-10BUY장외매수
바이오노트
bionote
-812.0K₩6,630-34.7%₩5.4B ($3.7M)
2025-01-23BUY장외매수
바이오노트
bionote
-1.4M₩7,440-41.8%₩10.6B ($7.4M)
2025-01-23SELL장외매도
이민구
Lee Min-gu
--1.4M₩7,440+41.8%₩10.6B ($7.4M)

Frequently asked questions

Who has been buying CTC Bio stock?
0 distinct insiders have filed 0 disclosed insider purchases in CTC Bio (060590), most recently on 2025-10-27. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does CTC Bio have?
CTC Bio has 0 buy-side and 0 sell-side disclosures on record, spanning 2025-01-23 to 2025-10-27.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.